Marburg Virus

Dear Colleagues,

Marburg virus disease (MVD) remains one of the most concerning viral hemorrhagic fevers due to its high mortality rate and limited treatment options. Caused by the Marburg virus (MARV), a member of the Filoviridae family, this disease poses a significant threat to public health, particularly in regions experiencing zoonotic spillover events and outbreaks. MARV infection is characterized by severe clinical presentations, necessitating an in-depth understanding of the virus’s epidemiology, pathogen-host interactions, immune responses, mechanisms of immune evasion, and current insights on vaccine and therapeutics development. This Special Issue on "Marburg Virus" aims to provide a comprehensive platform for current research and insights into all aspects of Marburg virus disease, from epidemiological patterns to advancements in vaccines and therapeutic interventions. Contributions that enhance our understanding of MARV immune responses, host defense mechanisms, and the public health impact are particularly encouraged. We welcome the submission of high-quality original research articles, reviews, and commentaries that address a broad range of topics, including but not limited to epidemiology, pathogen-host interactions, immune response and defense mechanisms, vaccine and therapeutic development, treatment, and public health implications. This issue is intended to serve as a comprehensive resource for researchers, healthcare professionals, and policymakers. We encourage submissions from diverse scientific disciplines, including virology, immunology, epidemiology, and public health.

Dr. Tafadzwa Dzinamarira
Prof. Dr. Claude Mambo Muvunyi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.